Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The role of compliance with PAP use on blood pressure in patients with obstructive sleep apnea: is longer use a key-factor?

Abstract

Scientific data about the effects of positive airway pressure (PAP) treatment on blood pressure (BP) control are continuously increasing; however, they are controversial. We aimed to determine the long-term effects of compliance with PAP therapy on BP in both hypertensive and normotensive patients with obstructive sleep apnea–hypopnea syndrome (OSAHS). One thousand one hundred sixty eight consecutive patients with newly diagnosed OSAHS, who had been recommended PAP therapy, were followed up for a minimum of 2 years. Patients with previous cardiovascular disease were excluded. BP was measured at baseline and after 2 years of PAP treatment. In addition, the correlation between the changes in BP with different levels of PAP compliance was assessed. At the end of the follow-up period, in the hypertensive group of patients (n=586), a significant decrease was shown in systolic (−11.2 mm Hg, P<0.001) and diastolic BP (−4.2 mm Hg, P<0.001). Furthermore, in the patients without hypertension (n=528), a significant decrease was noted both in systolic and diastolic BP (−3.6, P<0.001 and −2.4, P<0.001, respectively). A correlation between the magnitude of change in systolic and diastolic BP and hours of use of PAP (r=0.14, P=0.002 and r=0.1, P=0.025, respectively) was observed in all patients. Long-term use of PAP treatment, as well as increased hours of PAP in patients with OSAHS use showed significant reductions in BP not only in patients with hypertension, but also in normotensive patients. Therefore a significant potential reduction in cardiovascular mortality and morbidity should be expected in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  2. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118: 1080–1111.

    Article  Google Scholar 

  3. Kohler M, Stradling JR . Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010; 7: 677–685.

    Article  Google Scholar 

  4. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011; 27: 415–433, e1-e2.

    Article  Google Scholar 

  5. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510–e526.

    Article  Google Scholar 

  6. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011; 57: 2037–2114.

    Article  Google Scholar 

  7. Calhoun DA . Obstructive sleep apnea and hypertension. Curr Hypertens Rep 2010; 12: 189–195.

    Article  Google Scholar 

  8. Peppard PE, Young T, Palta M, Skatrud J . Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–1384.

    Article  CAS  Google Scholar 

  9. Cano-Pumarega I, Duran-Cantolla J, Aizpuru F, Miranda-Serrano E, Rubio R, Martínez-Null C et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the vitoria sleep cohort. Am J Respir Crit Care Med 2011; 184: 1299–1304.

    Article  Google Scholar 

  10. Marin JM, Carrizo SJ, Vicente E, Agusti AG . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.

    Article  Google Scholar 

  11. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241–247.

    Article  CAS  Google Scholar 

  12. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.

    Article  Google Scholar 

  13. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta- analysis of randomized controlled trials. Lung 2007; 185: 67–72.

    Article  CAS  Google Scholar 

  14. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757–764.

    Article  Google Scholar 

  15. Denker MG, Cohen DL . Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension. Curr Opin Nephrol Hypertens 2014; 23: 462–467.

    Article  Google Scholar 

  16. Bouloukaki I, Giannadaki K, Mermigkis C, Tzanakis N, Mauroudi E, Moniaki V et al. Intensive versus standard follow-up to improve continuous positive airway pressure compliance. Eur Respir J 2014; 44: 1262–1274.

    Article  Google Scholar 

  17. Johns MW . A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540–545.

    Article  CAS  Google Scholar 

  18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  Google Scholar 

  19. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111: 697–716.

    Article  Google Scholar 

  20. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462–1536.

    Google Scholar 

  21. Iber K, Ancoli-Israel S, Chesson AL, Quan SF . The AASM Manual for the Scoring of Sleep and Associated Events. American Academy of Sleep Medicine: Westchester, IL, USA, 2007.

    Google Scholar 

  22. Schwab RJ, Badr SM, Epstein LJ, Gay PC, Gozal D, Kohler M et al. An official American Thoracic Society statement: continuous positive airway pressure adherence trackingsystems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med 2013; 188: 613–620.

    Article  Google Scholar 

  23. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am J Respir Crit Care Med 1993; 147: 887–895.

    CAS  Google Scholar 

  24. Weaver TE, Mailsin G, Dinges DF, Bloxham T, George CF, Greenberg H et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007; 30: 711–719.

    Article  Google Scholar 

  25. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T . Nasal continuous positive airway pressure changes blood pressure ‘non-dippers’ to ‘dippers’ in patients with obstructive sleep apnea. Sleep 1999; 22: 849–853.

    Article  CAS  Google Scholar 

  26. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T . Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment. Am J Hypertens 1989; 2: 847–852.

    Article  CAS  Google Scholar 

  27. Tun Y, Hida W, Okabe S, Ogawa H, Kikuchi Y, Oikawa M et al. Can nasal continuous positive airway pressure decrease clinic blood pressure in patients with obstructive sleep apnea? Tohoku J Exp Med 2003; 201: 181–190.

    Article  Google Scholar 

  28. Voogel AJ, van Steenwijk RP, Karemaker JM, van Montfrans GA . Effects of treatment of obstructive sleep apnea on circadian hemodynamics. J Auton Nerv Syst 1999; 77: 177–183.

    Article  CAS  Google Scholar 

  29. Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FL, Fletcher PJ et al. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993; 16: 539–544.

    Article  CAS  Google Scholar 

  30. Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized parallel trial. Lancet 2002; 359: 204–210.

    Article  Google Scholar 

  31. Faccendia J, Mackay TW, Bood NA, Douglas NJ . Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344–348.

    Article  Google Scholar 

  32. Akashiba T, Kurashina K, Minemura H, Yamamoto H, Horie T . Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Intern Med 1995; 34: 528–532.

    Article  CAS  Google Scholar 

  33. Blondet MC, Perez J, Rodriguez W . Continuous positive airway pressure and obstructive sleep apnea in an Hispanic population. Sleep Breath 2001; 5: 109–114.

    Article  CAS  Google Scholar 

  34. Borgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Büchner N et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressurelowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens 2004; 17: 1081–1087.

    Article  Google Scholar 

  35. Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T . Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37: 1009–1013.

    Article  CAS  Google Scholar 

  36. Sanner BM, Tepel M, Markmann A, Zidek W . Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 2002; 15: 251–257.

    Article  Google Scholar 

  37. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ . Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea-hypopnea syndrome: Effects in ‘non-dippers. Sleep 1996; 19: 378–381.

    Article  CAS  Google Scholar 

  38. Dimsdale JE, Loredo JS, Profant J . Effect of continuous positive pressure on blood pressure placebo trial. Hypertension 2000; 35: 144–147.

    Article  CAS  Google Scholar 

  39. Ali NJ, Davies RJ, Fleetham JA, Stradling JR . The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 1992; 101: 1526–1532.

    Article  CAS  Google Scholar 

  40. Bazzano LA, Khan Z, Reynolds K, He J . Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50: 417–423.

    Article  CAS  Google Scholar 

  41. Robinson GV, Smith DM, Langford SA, Davies RJO, Stradling JR . Continuous positive airway pressure does not reduce blood pressure in non sleepy hypertensive OSA patients. Eur Respir J 2006; 27: 1229–1235.

    Article  CAS  Google Scholar 

  42. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M et al. Effects of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006; 129: 1459–1467.

    Article  Google Scholar 

  43. Dura´n-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Tera´n-Santos J, Aguirregomoscorta JI et al. Spanish Sleep and Breathing Group. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ 2010; 341: c5991.

    Article  Google Scholar 

  44. Suzuki M, Otsuka K, Guilleminault C . Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993; 16: 545–549.

    Article  CAS  Google Scholar 

  45. Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A et al. Continuous positive airway pressure treatment in sleep apnea with resistant hypertension: a randomized, controlled trial. J Hypertens 2010; 28: 2161–2218.

    Article  CAS  Google Scholar 

  46. Kasiakogias A, Tsioufis C, Thomopoulos C, Aragiannis D, Alchanatis M, Tousoulis D et al. Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up. J Hypertens 2013; 31: 352–360.

    Article  CAS  Google Scholar 

  47. Huang Z, Liu Z, Luo Q, Zhao Q, Zhao Z, Ma X et al. Long-term effects of continuous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea: a randomized controlled trial. Am J Hypertens 2015; 28: 300–306.

    Article  Google Scholar 

  48. Pepin JL, Tamisier R, Barone-Rochette G, Launois SH, Levy P, Baguet JP . Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 182: 954–960.

    Article  CAS  Google Scholar 

  49. Barbe F, Duran-Cantolla J, Capote F, de la Pena M, Chiner E, Masa JF et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718–726.

    Article  Google Scholar 

  50. Montesi SB, Edwards BA, Malhotra A, Bakker JP . The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012; 8: 587–596.

    PubMed  PubMed Central  Google Scholar 

  51. Furukawa T, Suzuki M, Ochiai M, Kawashima H, Yokoyama N, Isshiki T . Long-term adherence to nasal continuous positive airway pressure therapy by hypertensive patients with preexisting sleep apnea. J Cardiol 2014; 63: 281–285.

    Article  Google Scholar 

  52. Drager LF, Pedrosa RP, Diniz PM, Diegues-Silva L, Marcondes B, Couto RB et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011; 57: 549–555.

    Article  CAS  Google Scholar 

  53. Yorgun H, Kabakçi G, Canpolat U, Kirmizigül E, Sahiner L, Ates AH et al. Predictors of blood pressure reduction with nocturnal continuous positive airway pressure therapy in patients with obstructive sleep apnea and prehypertension. Angiology 2014; 65: 98–103.

    Article  CAS  Google Scholar 

  54. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  55. Goff DC Jr, Lloyd-Jones DM, Bennett G, O’Donnell CJ, Coady S, Robinson J et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 2014; 63: 2935–2959.

    Article  Google Scholar 

  56. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507–520.

    Article  CAS  Google Scholar 

  57. Hein H . Is sham CPAP a true placebo? Am J Respir Crit Care Med 2002; 165: 305.

    Article  Google Scholar 

  58. Baguet JP, Boutin I, Barone-Rochette G, Levy P, Tamisier R, Pierre H et al. Hypertension diagnosis in obstructive sleep apnea: self or 24-hour ambulatory blood pressure monitoring? Int J Cardiol 2013; 167: 2346–2347.

    Article  Google Scholar 

  59. Heude E, Bourgin P, Feigel P, Escourrou P . Ambulatory monitoring of blood pressure disturbs sleep and raises systolic pressure at night in patients suspected of suffering from sleep-disordered breathing. Clin Sci (Colch) 1996; 91: 45–50.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I Bouloukaki.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Author contributions

All authors were involved in data analysis/interpretation, drafting the article, critical revision of the article and approval of the final article. NT conducted the statistical analysis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bouloukaki, I., Mermigkis, C., Tzanakis, N. et al. The role of compliance with PAP use on blood pressure in patients with obstructive sleep apnea: is longer use a key-factor?. J Hum Hypertens 31, 106–115 (2017). https://doi.org/10.1038/jhh.2016.47

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2016.47

This article is cited by

Search

Quick links